Literature DB >> 14764702

Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages: role of p38 mitogen-activated protein kinase and NF-kappa B.

Wataru Matsuyama1, Lihua Wang, William L Farrar, Michel Faure, Teizo Yoshimura.   

Abstract

Macrophages produce an array of proinflammatory mediators at sites of inflammation and contribute to the development of inflammatory responses. Important roles for cytokines, such as IL-1 or TNF-alpha, and bacterial products, such as LPS, in this process have been well documented; however, the role for the extracellular matrix proteins, such as collagen, remains unclear. We previously reported that discoidin domain receptor 1 (DDR1), a nonintegrin collagen receptor, is expressed during differentiation of human monocytes into macrophages, and the interaction of the DDR1b isoform with collagen facilitates their differentiation via the p38 mitogen-activated protein kinase (MAPK) pathway. In this study, we report that the interaction of DDR1b with collagen up-regulates the production of IL-8, macrophage inflammatory protein-1alpha, and monocyte chemoattractant protein-1 in human macrophages in a p38 MAPK- and NF-kappaB-dependent manner. p38 MAPK was critical for DDR1b-mediated, increased NF-kappaB trans-activity, but not for IkappaB degradation or NF-kappaB nuclear translocation, suggesting a role for p38 MAPK in the modification of NF-kappaB. DDR1b-mediated IkappaB degradation was mediated through the recruitment of the adaptor protein Shc to the LXNPXY motif of the receptor and the downstream TNFR-associated factor 6/NF-kappaB activator 1 signaling cascade. Taken together, our study has identified NF-kappaB as a novel target of DDR1b signaling and provided a novel mechanism by which tissue-infiltrating macrophages produce large amounts of chemokines during the development of inflammatory diseases. Intervention of DDR1b signaling may be useful to control inflammatory diseases in which these proteins play an important role.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764702     DOI: 10.4049/jimmunol.172.4.2332

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  Loss of Discoidin Domain Receptor 1 Predisposes Mice to Periodontal Breakdown.

Authors:  M B Chavez; T N Kolli; M H Tan; C Zachariadou; C Wang; M C Embree; E J Lira Dos Santos; F H Nociti; Y Wang; D N Tatakis; G Agarwal; B L Foster
Journal:  J Dent Res       Date:  2019-10-14       Impact factor: 6.116

2.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

3.  Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Authors:  Dominique Guerrot; Monique Kerroch; Sandrine Placier; Sophie Vandermeersch; Claire Trivin; Mouna Mael-Ainin; Christos Chatziantoniou; Jean-Claude Dussaule
Journal:  Am J Pathol       Date:  2011-05-13       Impact factor: 4.307

4.  Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis.

Authors:  Wataru Matsuyama; Masaki Watanabe; Yuko Shirahama; Hideo Mitsuyama; Ikkou Higashimoto; Mitsuhiro Osame; Kimiyoshi Arimura
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.

Authors:  Zhen Wang; Yali Zhang; Sergio G Bartual; Jinfeng Luo; Tingting Xu; Wenting Du; Qiuju Xun; Zhengchao Tu; Rolf A Brekken; Xiaomei Ren; Alex N Bullock; Guang Liang; Xiaoyun Lu; Ke Ding
Journal:  ACS Med Chem Lett       Date:  2017-02-09       Impact factor: 4.345

Review 6.  Discoidin domain receptor 1: a new class of receptor regulating leukocyte-collagen interaction.

Authors:  Teizo Yoshimura; Wataru Matsuyama; Hidenobu Kamohara
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Clinical investigation: increased serum stromal derived factor 1 alpha levels in pulmonary tuberculosis.

Authors:  K Mizuno; W Matsuyama; H Mitsuyama; M Watanabe; I Higashimoto; M Osame; K Arimura
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

8.  RNA interference as a potential therapeutic treatment for inflammation associated lung injury.

Authors:  Joanne Lomas-Neira; Chun-Shiang Chung; Alfred Ayala
Journal:  Int J Clin Exp Med       Date:  2008-02-25

9.  The type 1 diabetes - HLA susceptibility interactome--identification of HLA genotype-specific disease genes for type 1 diabetes.

Authors:  Caroline Brorsson; Niclas Tue Hansen; Regine Bergholdt; Søren Brunak; Flemming Pociot
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

10.  Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.

Authors:  Hang Yin; Lee Chao; Julie Chao
Journal:  Life Sci       Date:  2007-11-09       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.